1.Clinicopathologic characteristics andtherapeutic responses ofChinese patients withnon-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement
ShaFu ; HaiYunWang ; FangWang ; MaYanHuang ; LingDeng ; XiaoZhang ; ZuLuYe ; Shao JIANYONG
Chinese Journal of Cancer 2015;(9):404-412
Introduction:The rearrangement of the anaplastic lymphoma kinase (ALK) gene accounts for approximately 1%–6%of lung adenocarcinoma cases and deifnes a molecular subgroup of tumors characterized by clinical sensitivity toALK inhibitors such as crizotinib. This study aimed to identify the relationship betweenALK rearrangement and the clinico?pathologic characteristics of non?small cell lung cancer (NSCLC) and to analyze the therapeutic responses of crizotinib and conventional chemotherapy toALK rearrangement in NSCLC patients. Methods:A total of 487 lung cancer patients who underwent testing forALK rearrangement in our department were included in this study.ALK rearrangement was examined by using lfuorescence insitu hybridization (FISH) assay. Results:Among the 487 patients, 44 (9.0%) were diagnosed withALK rearrangement by using FISH assay. In 123 patients with adenocarcinoma who were non?smokers and of a young age (≤58years old), the frequency ofALK rearrangement was 20.3% (25/123). Short overall survival (OS) was associated with non?adenocarcinoma tumor type (P=0.006), poorly differentiated tumors (P=0.001), advanced?stage tumors (P<0.001), smoking history (P=0.008), and wild?type epidermal growth factor receptor (EGFR) (P=0.008). Moreover, patients with poorly differentiated and advanced?stage tumors had a shorter time to cancer progression compared with those with well differentiated (P=0.023) and early?stage tumors (P=0.001), respectively. Conclusions:ALK?rearranged NSCLC tends to occur in younger individuals who are either non?smokers or light smokers with adenocarcinoma. Patients withALK rearrangement might beneift fromALK inhibitor therapy.
2.Application of ultrasound-guided temporary balloon occlusion in performing cesarean section for patients with pernicious placenta previa: initial results in 13 cases
Kunqian CHEN ; Fangwang LI ; Enquan ZHU ; Kui XIE ; Wenliang LI ; Mingli ZHANG ; Chao GENG ; Aiguo WANG ; Jianfeng LIU ; Hao GUO
Journal of Interventional Radiology 2017;26(10):915-917
Objective To discuss the clinical application of ultrasound-guided temporary balloon occlusion in performing cesarean section for patients with pernicious placenta previa.Methods At Qujing Municipal First People's Hospital,the Interventional Department and Ultrasonography Department assisted the Obstetrics Department to accomplished cesarean section for 13 patients with pernicious placenta previa.The diagnosis of central placenta previa was confirmed by both color ultrasound and MRI in all the 13 patients.Before cesarean section,the balloons were placed in bilateral common iliac arteries or in abdominal aorta,and the balloons were inflated at the same time when the fetus was delivered so as to temporarily obstruct the target vessels.Based on the hemostatic condition,the balloon was timely withdrawn.Results Among the 13 patients,temporary abdominal aorta occlusion was employed in one and temporary bilateral common iliac artery occlusion in 12.Ultrasound-guided occlusion was successfully accomplished in 12 patients,and the average blocking time was <15 min.The amount of intraoperative blood loss was 800-1500 ml.Conclusion Ultrasound-guided temporary balloon occlusion before cesarean section is safe with reliable effect in treating pernicious placenta previa,it can remarkably reduce the amount of intraoperative blood loos,and it has no X-ray radiation damage,therefore,this technique is worthy of clinical application.